5 Grants
2023
Sulfur Based Stem Cell Therapeutics in Necrotizing Enterocolitis
MARKEL, TROY A
National Institutes of Health (NIH), National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (ID: 1R01DK133418-01A1), $427,242USD, 2023-04-15 -- 2028-02-29
2021
Mesenchymal Stromal Cells Modulate Intestinal Mesenteric Endothelium Via Hydrogen Sulfide
MARKEL, TROY A
National Institutes of Health (NIH), National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (ID: 5K08DK113226-04), $150,278USD, 2018-06-01 -- 2022-05-31
2020
Mesenchymal Stromal Cells Modulate Intestinal Mesenteric Endothelium Via Hydrogen Sulfide
MARKEL, TROY A
National Institutes of Health (NIH), National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (ID: 5K08DK113226-03), $150,278USD, 2018-06-01 -- 2022-05-31
2019
Mesenchymal Stromal Cells Modulate Intestinal Mesenteric Endothelium Via Hydrogen Sulfide
MARKEL, TROY A
National Institutes of Health (NIH), National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (ID: 5K08DK113226-02), $150,278USD, 06/01/2018 -- 05/31/2022
2018
Mesenchymal Stromal Cells Modulate Intestinal Mesenteric Endothelium Via Hydrogen Sulfide
MARKEL, TROY A
National Institutes of Health (NIH), National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (ID: 1K08DK113226-01A1), $152,022USD, 06/01/2018 -- 05/31/2022